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Abstract
Hepatitis C virus (HCV) core protein is directed to the surface of lipid droplets (LD), a step that is essential for infectious virus
production. However, the process by which core is recruited from LD into nascent virus particles is not well understood. To
investigate the kinetics of core trafficking, we developed methods to image functional core protein in live, virus-producing
cells. During the peak of virus assembly, core formed polarized caps on large, immotile LDs, adjacent to putative sites of
assembly. In addition, LD-independent, motile puncta of core were found to traffic along microtubules. Importantly, core
was recruited from LDs into these puncta, and interaction between the viral NS2 and NS3-4A proteins was essential for this
recruitment process. These data reveal new aspects of core trafficking and identify a novel role for viral nonstructural
proteins in virus particle assembly.
Citation: Counihan NA, Rawlinson SM, Lindenbach BD (2011) Trafficking of Hepatitis C Virus Core Protein during Virus Particle Assembly. PLoS Pathog 7(10):
e1002302. doi:10.1371/journal.ppat.1002302
Editor: Aleem Siddiqui, University of California, San Diego, United States of America
Received February 28, 2011; Accepted August 22, 2011; Published October 20, 2011
Copyright:  2011 Counihan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by NIH grants AI076259 and AI087925 (both to B.D.L.) and the Leslie H Warner Fellowship in Cancer Research (to N.A.C.). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: brett.lindenbach@yale.edu
Introduction
Hepatitis C virus (HCV) is a major cause of acute and chronic
hepatitis, cirrhosis, and hepatocellular carcinoma. HCV is an
enveloped, positive-strand RNA virus classified with the Family
Flaviviridae [1]. The viral genome encodes an open reading frame of
<3011 codons that is translated as a single polyprotein, which is
cleaved by viral and host proteases into at least 10 distinct products
(Figure 1A). The N-terminal region encodes three structural
components: core protein, which forms the viral nucleocapsid,
and two envelope glycoproteins (E1 and E2), which mediate viral
attachment and entry. The remainder of the genome encodes the
nonstructural (NS) proteins: p7, NS2, NS3, NS4A, NS4B, NS5A
and NS5B. The NS proteins mediate intracellular aspects of the
virus life cycle including RNA replication, subversion of innate
antiviral defense, and virus particle assembly. The precise roles of
NS proteins in virus particle assembly are not clear but p7, NS2,
NS3, NS4A, NS4B, and NS5A all contribute to this process [2,3,4].
HCV core is a highly basic RNA-binding protein that contains
three distinct functional domains [5]. Domain 1 (amino acid (aa)
1–117) is hydrophilic and contains determinants for RNA binding
and core oligomerization [6]. Domain 2 (aa 118–177) forms a pair
of amphipathic helices that mediate the peripheral association of
core with cellular membranes [7,8,9]. Domain 3 (aa 178–191),
which serves as a signal peptide for the translocation of E1 protein
into the endoplasmic reticulum (ER) lumen, is absent from mature
core protein [5]. Core is initially cleaved from the polyprotein by
host signal peptidase (SP); subsequent removal of domain 3 by
signal peptide peptidase (SPP) then yields mature core protein that
forms a homodimer [6,9,10].
Following cleavage, mature core protein is targeted to lipid
droplets (LDs) [11,12,13]. LDs are intracellular storage organelles
containing a hydrophobic core of neutral lipids and cholesterol
esters surrounded by a phospholipid monolayer embedded with
LD-specific proteins [14]. LD biogenesis is not fully understood,
but LDs are likely derived from the outer leaflet of the ER and
may remain contiguous with this membrane system [15]. LD-
associated proteins are presumably loaded onto LDs at sites of ER
contact [16], although vesicular transport mechanisms have not
been formally excluded. The best-characterized LD-associated
proteins are perilipin, adipocyte differentiation-related protein
(ADRP), and tail-interacting protein (TIP) 47, collectively known
as the PAT proteins [17]. PAT proteins are thought to regulate the
dynamics of lipid acquisition, storage, and release [15]. In
addition, the membrane trafficking GTPase Rab18 may associate
with a subset of LDs undergoing lipolysis [18,19,20,21].
The role of core trafficking to LDs is not well understood. Prior
work has shown that core protein recruits NS proteins and RNA
replication complexes to sites adjacent to LDs [22]. Furthermore,
core recruits NS5A to the surface of LDs, where they co-localize
[23]. Mutations that alter the LD localization of core or that block
core’s ability to recruit viral NS proteins to LDs inhibit virus
production [22,24,25,26], suggesting that LDs are intimately
involved in virus particle assembly. The site of virus budding has
not been definitively determined, but the ER retention of E1-E2
[27,28], the complex glycan modifications on secreted virus
particles [29], the differential effects of Brefeldin A (BFA) on virus
assembly vs. virus secretion [30], and analogies to closely related
flaviviruses (reviewed in [31]), all suggest that virus particles bud
into the ER and transit through the secretory pathway. However,
it is not yet clear how LD-associated core contributes to this
process.
We hypothesize that core protein must be trafficked from LDs
into nascent virus particles at the LD-ER interface. To understand
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the dynamics of core protein trafficking during virus assembly, we
developed methods to fluorescently label and image functional
core protein in live, virus producing cells. We observed core
trafficking to static ADRP-positive LDs, forming a cap on the
surface. At these sites, core co-localized with the viral E2
glycoprotein and adjacent to NS3 protein, consistent with these
being sites of virus assembly. We also observed highly motile
ADRP-independent core puncta that represent post-LD form of
core. By using pharmacologic inhibitors of virus egress and a panel
of mutants blocked in virus assembly, we showed that core is
recruited from sites of assembly into these puncta, and that this
process requires interaction between viral NS proteins.
Results
Fluorescent labeling of functional HCV core protein
To better understand the trafficking of HCV core protein
during virus particle assembly, we developed methods to
fluorescently label and image functional core in living cells.
Traditional live imaging systems often rely on the insertion of
fluorescent proteins into a target protein, but the relatively large
size of such tags would likely interfere with the function of core
protein. We therefore genetically inserted the small tetracysteine
(TC) peptide tag (FLNCCPGCCMEP) near the N-terminus of
core (Figure 1B) within the context of the HCV Jc1 infectious
clone. Importantly, insertion of this tag had only minimal effects
on infectious virus production compared to untagged Jc1
(Figure 1C). For both untagged Jc1 and Jc1/core(TC), peak viral
infectivity was observed between 48 and 72 h post-electroporation,
although the infectivity titers of Jc1/core(TC) were slightly
reduced (2- to 4-fold) at each time point. This correlated with a
2.7-fold decrease in specific infectivity (0.16 Jc1 infectious units per
RNA-containing particle vs. 0.06 Jc1/core(TC) infectious units per
RNA-containing particle), suggesting that the small decrease in
infectivity titers may have been due to an inefficiency in virus entry
rather than in virus assembly. Both Jc1 and Jc1/core(TC) had
similar biophysical profiles, with peak infectivities and specific
infectivities observed in fractions with buoyant density of<1.10 g/ml
(Figures S1A and S1B). Furthermore, the TC-tagged form of core
accumulated to similar levels as untagged core within virus-producing
cells (Figure 1D), and the TC insertion was retained after six serial
virus passages (data not shown). Together, these data indicated that
the TC tag insertion was well tolerated and that the TC-tagged core
protein was functional for virus assembly.
To label core(TC), infected Huh-7.5 cells were incubated with
FlAsH (green) or ReAsH (red) under optimized labeling conditions
(as described in Materials and Methods) during the peak of virus
assembly, 48 to 72 h post-infection or electroporation (Figure 1C).
As shown in Figure 1E, specific signals were observed in Jc1/
core(TC)-infected cells, often as bright puncta or crescents
(Figure 1E, arrowhead), but not in Jc1-infected cells. Importantly,
these FlAsH labeling conditions had no effect on the release of
infectious virus particles (Figure 1F), indicating that these methods
allowed us to label functional core protein during virus assembly.
To further confirm that FlAsH-labeling was specific for core, Jc1/
core(TC)-infected cells were labeled with FlAsH, fixed, and stained
for core by IF (Figure 1G). FlAsH and anti-core IF signal largely
co-localized (Pearson’s correlation coefficient = 0.715), confirming
that FlAsH labeled core(TC) protein. However co-localization was
incomplete, largely due to the increased signal intensity of the IF
signal in a perinuclear, reticular pattern. This difference could be
attributable to one or more of the following issues. First, FlAsH
signal intensity decreased 4-fold during fixation and processing for
IF (Figure S2), mostly likely because this dye lacks an aldehyde-
reactive primary amine and may be washed out during processing.
Second, indirect IF is designed to amplify weak signals, whereas
FlAsH labeling binds stoichiometrically to the TC tag. Third,
FlAsH is less photostable than the Alexa dye used during IF, which
could bias the relative signal intensities. Fourth, small dyes and
antibodies may differ in their accessibility and efficiency of protein
labeling. Nevertheless, these data confirmed that the TC tag can
be used to label core protein in live, virus-producing cells.
Localization and kinetics of core protein in live cells
To better clarify the role of core LD-trafficking during virus
assembly, we created Huh-7.5-derived cell lines that stably
expressed ADRP, a marker of storage LDs, fused to green
fluorescent protein (GFP) or cerulean fluorescent protein (CFP). As
ADRP expression levels can influence LD metabolism [32], we
first characterized these cell lines for their ADRP expression, LD
content, and ability to support infectious HCV particle assembly.
Neither tagged-ADRP protein was overexpressed when compared
to endogenous levels of ADRP expression (Figure S3C). There was
a modest increase in the number of LDs in Huh-7.5/CFP-ADRP
cells (170.8667.89 LDs/cell) compared to Huh-7.59s (128.0653.1
LDs/cell), although this difference was not statistically significant
(p .0.05; unpaired Student’s t-test). Furthermore, there was no
difference in the volume of LDs, either with or without oleic acid
supplementation (Figure S3D). Importantly, both cell lines
supported infectious virus production at levels comparable to
non-transduced cells (Figure S3A–B). These data indicated that
the GFP-ADRP and CFP-ADRP cells provided suitable environ-
ments to study core-LD trafficking in live cells.
To investigate core trafficking, we performed ReAsH labeling
and live cell imaging of core(TC) in Huh-7.5/GFP-ADRP cells.
Across multiple experiments, core consistently localized to: i) a dim
reticular pattern, most likely the ER (Figure S3E) [13,22]; ii) caps on
ADRP-positive LDs; and iii) bright puncta that were not associated
with ADRP-positive LDs (Figure 2A). Notably, the caps of LD-
associated core protein frequently faced the ER-like form of core,
and core-positive LDs exhibited little directional movement
(Figure 2B, upper panel and Video S1). In contrast, ADRP-positive
LDs that lacked core were more motile. Furthermore, core puncta
were small and motile (Figure 2B, lower panel and Video S1).
Author Summary
Hepatitis C virus (HCV) infects almost 200 million people
worldwide, causing both acute and chronic liver disease.
Although some antiviral treatments exist, they are not fully
effective against all HCV genotypes and have serious side
effects. In order to develop more effective treatment
strategies, a better understanding of how HCV replicates in
infected cells is required. In our study, we developed
methods to visualize early steps in HCV particle assembly
by fluorescently labeling core protein, a structural com-
ponent of the virus. Soon after protein translation, core
trafficked to the surface of large, immobile lipid droplets
that were adjacent to sites of virus assembly. Core was also
observed in highly motile puncta that traveled along
microtubules. By using inhibitors of virus assembly and
assembly-deficient viral mutants, we showed that core is
recruited from lipid droplets into these puncta, and that
this process was mediated by the interaction of HCV
nonstructural proteins. Our work describes new methods
to study the trafficking of core protein in infected cells,
allowing us to better define aspects of infectious HCV
particle assembly.
Live Cell Imaging of Functional HCV Core Protein
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Given the velocity of core puncta, we examined whether they
were associated with microtubules by performing live cell imaging in
Huh-7.5 cells that stably expressed fluorescent protein-tagged ß-
tubulin. As shown in Video S2, core puncta trafficked along
microtubules, frequently in a retrograde direction. In contrast, motile
core puncta were not associated with fluorescent protein-tagged
actin filaments (data not shown). Furthermore the motility of core
puncta was inhibited by nocodazole, an inhibitor of microtubule
trafficking (Figure 2C and Video S3). These data indicated that
motile core puncta were trafficked on microtubules.
To better clarify the interaction of core with LDs, and to
determine whether core puncta represent small LDs that lack
ADRP, we examined additional LD markers. Staining with a dye
specific for neutral lipids confirmed that core localized to semi-
spherical caps on the surface of LDs and to small LD-independent
puncta (Figure S3F). Furthermore, LD-associated core specifically
trafficked to ADRP-positive LDs but not to Rab18-positive LDs
(Figures S3G and H), which likely represent LDs undergoing lipolysis
[33]. These data confirmed that core trafficked to ADRP-positive
LDs and to distinct motile puncta that were not LD-associated.
To determine whether the different forms of core corresponded
to sites of virus particle assembly, we examined the localization of
core with respect to the viral E2 glycoprotein (a structural
component of virus particles) or NS3 serine protease-RNA helicase
(a NS protein that has been implicated in virus assembly). Since we
currently lack tools to image functional E2 and NS3 in live cells,
Figure 1. Fluorescent labeling of functional HCV core protein. (A) Schematic of HCV genome and polyprotein. The open bullet represents a
signal peptide peptidase cleavage site; closed bullets represent signal peptidase cleavage sites; the open arrowhead represents the NS2–3 cysteine
autoprotease cleavage site; closed arrowheads represent NS3-4A serine protease cleavage sites. (B) Schematic of TC tag inserted into the C terminus
of core to create Jc1/core(TC). (C) Time course of Jc1 (closed circle) and Jc1/core(TC) (open circle) virus production after RNA electroporation. Values
are averages of results from three independent transfections 6 SEM. The grey line shows the limit of detection of this assay; the asterisk denotes the
timepoint at which infectivity titers were significantly different (Student’s unpaired t-test, p ,0.05); NS denotes timepoints where the differences in
infectivity titers were not statistically significant (p .0.05). (D) Western blot analysis of core protein expression from cells lysed at 48 h post-
electroporation with the indicated viral transcript. Actin is shown as a loading control. (E) Live cell imaging of core protein. Huh-7.5 cells were infected
with Jc1 or Jc1/core(TC) and labeled with FlAsH at 48 h post-infection. TC-tagged core was frequently observed in crescent structures (top panel,
arrowhead) and in small puncta. Background signals were minimal with untagged Jc1 (bottom panel). (F) Effect of FlAsH labeling on virus assembly.
Huh-7.5 cells were infected with Jc1/core(TC) and labeled with FlAsH or a mock label at 48 h post-infection. Supernatants were collected at 2, 4, 8, and
24 h post-labeling and titrated for infectivity. Values are averages from three replicates6 SEM. The grey line shows the limit of detection of this assay.
No statistically significant difference (unpaired Student’s t-test, p .0.05) was observed between FlAsH and mock-labeled cells at any time point. (G)
Specificity of biarsenical labeling for core protein. Huh-7.5 cells were infected with Jc1 or Jc1/core(TC), labeled with FlAsH at 48 h post-infection, then
fixed and stained for IF with anti-core antibody. Co-localization was observed in the merged image. For all micrographs, scale bars represent 10 mm.
doi:10.1371/journal.ppat.1002302.g001
Live Cell Imaging of Functional HCV Core Protein
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these viral proteins were localized by IF in fixed cells. As seen in
Figure 2D, the majority of E2 staining was in a reticular pattern,
consistent with its ER retention, as well as discrete E2 puncta that
co-localized with core (Figure 2D, arrowheads). These core-E2
structures were frequently found adjacent to small LDs and may
represent areas where core has been recruited from LDs into
nascent virus particles. The frequency of such core-E2 puncta was
low (2.8660.54 per cell, n = 28 cells), which could reflect the low
burst size of HCV as well as the inherent difficulties with antibody
recognition of E2 [34]. In addition, we also observed core puncta
that were not labeled with E2. Similarly, NS3 also showed a reticular
staining pattern, but frequently concentrated in regions adjacent to
LD-associated caps of core protein (Figure 2E, arrowheads). For
further characterization, we looked for co-localization of core with
Figure 2. Localization and kinetics of core protein in live cells. (A) Localization of core in Huh-7.5 cells. Cells expressing GFP-ADRP were
labeled with ReAsH at 48 h post-infection. Three forms of core were observed; i) ER-associated core; ii) core associated with ADRP-positive LDs; (iii)
ADRP-independent core puncta. Panels show a magnification of ADRP-associated core as a cap on LDs (ii), and ADRP-independent core puncta (iii).
Contrast was enhanced to show ER-associated core. Nuclei (N) are marked for reference. (B) Kinetics of intracellular core protein movement. The
velocities of three representative LD-associated core particles (from Figure 2Aii) and core puncta (from Figure 2Aiii) were determined over the course
of 45 minutes (0.75 frame/min) and the velocity at each timepoint shown. Individual particles were tracked by using Volocity Quantitation software.
(C) Core puncta are sensitive to treatment with Nocodazole. Cells expressing GFP-ADRP were labeled with ReAsH at 48 h post-infection, then treated
with 50 mM Nocodazole for 1 h. The velocity of individual ADRP-independent core particles in treated and untreated samples (n = 26) was determined
over 10 frames (1 frame/min) by using Volocity Quantitation software. Values show average velocity of each particle over 10 frames, horizontal bars
represent mean values of each group. The mean velocity of Nocodazole-treated cells was significantly different to non-treated cells (unpaired
Student’s t-test). (D–E) Co-localization of core with E2 and NS3. Cells expressing ADRP-CFP were labeled with FlAsH at 48 h post-infection, then fixed
and stained for IF with anti-E2 (D) or anti-NS3 (E) antibodies. Nuclei (N) are shown for reference in the merged images. (D) Puncta of core co-localized
with E2 puncta in areas adjacent to LDs (arrowheads). (E) NS3 localized to LDs containing caps of core (arrowheads). (F) Localization of core in ADRP-
CFP-expressing cells electroporated with the indicated viral transcript (WT, wild type). Panels show ADRP, core, and merged images. The D88 mutant
showed enhanced accumulation of core around LDs. For all micrographs, scale bars represent 10 mm.
doi:10.1371/journal.ppat.1002302.g002
Live Cell Imaging of Functional HCV Core Protein
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other components of the secretory compartment, including markers
for ER exit sites (Sec16, Sec23), the ER-Golgi intermediate
compartment (ERGIC-58), and Golgi (TGN38), but did not
reproducibly observe co-localization with these markers (data not
shown). Based on these data, we hypothesize that LD-associated core
caps likely represent sites of early virus particle assembly, while
motile puncta may represent core-containing transport vesicles.
To further clarify the relationship between core trafficking and
virus particle assembly, we examined core trafficking in a mutant
virus, D88, which is blocked at an early stage of virus particle
assembly due to a large in-frame deletion in the E1-E2-p7 genes
[35]. The Jc1/core(TC) D88 mutant showed a substantial increase
in core accumulation on the surface of LDs (Figures 2F, S3I).
While a small number of core puncta were observed, they were
non-motile (Video S4), indicating that they were distinct from the
motile core puncta seen in virus-producing cells. While it is not yet
clear what these non-motile core puncta represent, these data
showed that core accumulates on LDs and that motile core puncta
were not seen when virus assembly was blocked at an early step.
Effects of Brefeldin A on core localization
Our previous results suggested that motile core puncta may
represent a post LD-form of core. To further investigate this
hypothesis, we treated cells with BFA, a fungal metabolite that
disrupts ER-Golgi trafficking by inhibiting the activation of ADP
ribosylation factor 1 (ARF1) [36]. The timing and dose of BFA
treatment were chosen to minimize effects on HCV RNA
replication [37]. Consistent with previous findings [38], BFA
treatment inhibited the secretion of virus particles as well as a
model secreted protein, causing them to accumulate within BFA-
treated cells (Figure S4A–B). As ARF1 can regulate lipid
homeostasis [39,40,41], we also checked whether our conditions
affected LD trafficking. Our BFA treatment conditions had only
minimal effects on ADRP protein expression, LD number, and
LD volume (Figure S4C), indicating that these conditions could
be used to study the trafficking of core protein when ARF1 is
inhibited.
To observe the effects of BFA on core localization, cells were
imaged before and after BFA treatment, as well as after drug
washout (Figure 3A). BFA treatment increased both the number of
LDs containing core and the amount of core that accumulated on
each LD (Figure 3B–D), suggesting a defect in core egress from
LDs. After drug washout, both of these effects were relieved
(Figure 3B–D). BFA treatment resulted in a slight reduction of LD-
independent core puncta at 4 h (Figure 3E); however, these puncta
were not motile when BFA was present (Video S5 and Figure 3I).
Upon BFA washout, more core puncta were observed (Figures 3E,
3H) and core puncta quickly regained their motility (Video S6 and
Figure 3I). These effects were mirrored in the intracellular
accumulation of virus during BFA treatment and an increase in
virus secretion after BFA washout (Figures 3F and 3G). The
absence of motile core puncta during BFA treatment and their re-
emergence upon washout suggests that they represent a post-LD
form of core.
Long-term dynamics of core trafficking
Based on the above results, we expected to observe the
trafficking of core from LDs into motile core puncta during live
imaging studies. However, these events may be relatively rare, and
FlAsH and ReAsH are prone to photobleaching, which greatly
limited the number of sequential frames that could be acquired
during time course experiments. To better monitor core trafficking
over time, we took advantage of the dual labeling capabilities of
biarsenical dyes [42]. We reasoned that infected cells could be
sequentially labeled under pulse-chase conditions, first with FlAsH
to label pre-existing (‘‘old’’) core, followed by ReAsH to specifically
detect newly synthesized (‘‘new’’) core. Pilot experiments showed
that simultaneous labeling of Jc1/core(TC)-infected cells with both
FlAsH and ReAsH yielded green and red signals that completely
overlapped, indicating that both dyes bind TC-tagged core with
similar efficiency (data not shown). Next, infected cells were
labeled with FlAsH, then labeled with ReAsH after appropriate
intervals (Figure 4A). Under these conditions, newly synthesized
protein was specifically detected with ReAsH, but not when
protein synthesis was halted by cycloheximide treatment during
the chase period (Figure 4B, compare second and third rows).
Furthermore, newly synthesized core did not traffic to LDs when
the maturation of core was blocked by treatment with an inhibitor
of signal peptide peptidase but was restored after washout of this
inhibitor (Figure S5). These data confirmed that the dual labeling
technique could be used to specifically label and image old and
new core under pulse-chase conditions.
We used dual labeling to observe the trafficking of core
synthesized before and after chase periods of 2, 8, and 24 h
(Figure 4B). After 2 h, a small amount of newly synthesized core
was detected in an ER-like reticular pattern or co-localized with
old core in LD-associated caps (Figure 4B, top row). By 8 h, new
core and old core had accumulated on LDs to comparable levels,
and mixed puncta (containing both old and new core) were
abundant (Figure 4B, second row). By 24 h, new core was the
predominant species in both LDs and motile core puncta
(Figure 4B, bottom row). Similar results were also obtained when
the order of FlAsH- and ReAsH-labeling were switched (data
not shown).
In order to observe the trends of core trafficking, we quantitated
LDs and motile core puncta that contained old, new, or mixed
core protein over time (Figure 4C). These data yielded several
interesting results. First, newly synthesized core was targeted to
LDs shortly after synthesis. Second, the mixing of old and new
core on LDs at 8 h indicated that core-containing LDs maintain
communication with the site of core synthesis for extended periods
of time (see Discussion). Third, the peak of mixed core in puncta (8
h) was observed after the peak of mixed core on LDs (2 h), further
supporting our hypothesis that motile core puncta represent a
post-LD form of core. Fourth, the small proportion of motile
puncta containing old and mixed core at 24 h suggested that once
core leaves LDs, it is either packaged into virus particles for
secretion, or turned over.
The interaction between NS2 and NS3 is essential for
recruiting core from LDs
We next examined the role of NS2 in core trafficking. Prior
genetic and biochemical studies indicated that NS2 plays an
important role in virus assembly by bringing together the viral E1–
E2 glycoprotein and NS3-4A enzyme complexes [4,43,44,45]. We
previously identified two classes of NS2 mutants with defects in
virus assembly [45,46]. Class 1 mutants (NS2 K27A, W35A, or
Y39A) show reduced interaction between NS2 and NS3, and their
defects in virus assembly can be suppressed by a second-site
mutation in the helicase domain of NS3, Q221L [45,46]. A class 2
mutant (NS2 K81A) has normal levels of NS2–NS3 interaction but
reduced interaction between NS2 and E1–E2, and its defect in
virus assembly can be suppressed by a second site mutation in E1,
E78T [45,46]. When the class 1 NS2 mutation K27A was
introduced into Jc1/core(TC), the amount of core staining per cell
increased, and specifically, core accumulated on LDs (Figures 5A
and 5B), similar to what was previously observed with the D88
mutation. The addition of the NS3 Q221L suppressor restored
Live Cell Imaging of Functional HCV Core Protein
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Figure 3. Effects of Brefeldin A on core localization. (A) Schematic of experimental design. Huh-7.5 cells expressing fluorescent protein-tagged
ADRP were FlAsH-labeled at 48 h post-infection. Parallel sets of cells were treated with 1 mg/ml BFA for 4 h before drug wash out. Cells were fixed
before (0 h) and after (4 h) BFA treatment and also during washout (6 h and 8 h), as indicated by open circles. (B) BFA treatment caused an increase in
ADRP-associated core. Images of cells fixed after BFA treatment (4 h) and after washout (6 h). (C–E) Quantitation of images from each time point
(n$19). Image quantification was performed as described in Materials and Methods. All values show mean6 SEM, p values were calculated by using
an unpaired Student’s t-test. (C) BFA treatment causes accumulation of core-containing LDs. The mean number of core-containing LDs per cell was
calculated for each time point. (D) BFA treatment increases the amount of core on each LD. The mean proportion of LD surface area occupied by core
(expressed as a percentage) was calculated for each time point. (E) BFA washout increases the number of non-LD core puncta. The mean number of
core puncta per cell was calculated for each time point. (F–G) Effects of BFA treatment on infectious HCV production. Triplicate samples of cells (F) or
supernatants (G) that had been treated with BFA (1 mg/ml) were collected at the times shown in Figure 3A. Mean virus titers for untreated (black) or
BFA-treated (blue) samples are shown for each time point (6 SEM). The grey line shows the limit of detection of each assay. (H) Formation of core
puncta after BFA washout. Cells expressing tagged-ADRP were treated with BFA (1 mg/ml) for 3 h and labeled with FlAsH. BFA was removed by
multiple washes with HBSS immediately prior to imaging. Images were collected every hour from the time BFA was washed out (0 h). Arrowheads
show newly formed puncta at each time point. For all micrographs, scale bars represent 10 mm. (I) Core motility during BFA treatment and shortly
after drug washout. Three core puncta were randomly chosen from representative time courses (see Videos S5 and S6); their velocities were
calculated by using Volocity Quantitation software and plotted over time.
doi:10.1371/journal.ppat.1002302.g003
Live Cell Imaging of Functional HCV Core Protein
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normal core trafficking (Figures 5A and 5B). Based on these
results, we tested additional NS2 mutants. All class 1 NS2 mutants
showed increased intracellular accumulation of core (Figure 5C,
left panel), and specifically, core localized to LDs (Figure S6A).
Furthermore, core accumulation was restored to WT levels by the
NS3 Q221 suppressor mutation (Figure 5C, right panel). In
contrast, the class 2 NS2 mutant, K81A, did not show these effects
(Figure 5C). These results were further confirmed by core IF with
the untagged Jc1/NS2(K27A) mutant in non-transduced Huh-7.5
cells (Figure S6B). Taken together, these data indicated that the
genetic interaction between NS2 and NS3 is important for proper
egress of core from the surface of LDs.
To further clarify whether the interaction between NS2 and
NS3 is important for the recruitment of core from LDs into core
puncta, we performed FlAsH/ReAsH-dual labeling and quanti-
tated LD-associated core and motile core puncta between 48 and
72 h post-electroporation. The NS2 Y39A mutant was used for
these experiments because it showed the greatest accumulation of
core (Figure 5C). At all time points, the Y39A mutant showed an
abundance of LDs containing old core and few LDs containing
mixed or new core (Figure 5D, left panel). In contrast, the Y39A +
Q221L double mutant showed LDs containing a mixture of
old, new, and mixed core (Figure 5E, left panel), which was
qualitatively similar to WT (Figure 4C, top panel). Importantly,
the number of motile core puncta, especially those containing new
core, was significantly reduced in the Y39A mutant (Figure 5D,
right panel) but was restored in the Y39A + Q221L double mutant
(Figure 5E, right panel). Taken together, we conclude that the
interaction between NS2 and NS3 is important for the recruitment
of core from LDs into motile core puncta.
Discussion
We developed methods to image functional core protein in live,
virus-producing cells. The small size of the TC tag offered several
advantages over fluorescent protein tagging, namely that tagged
proteins are more likely to retain native function, and do not require
lengthy maturation of protein-encoded fluorophores. Additionally,
Figure 4. Long term dynamics of core trafficking. (A) Schematic of experimental design. Parallel cultures of Huh-7.5 cells expressing ADRP-CFP
were labeled with FlAsH at 48 h post-infection (green bar) then incubated for 2, 8, or 24 h. At the indicated times, cells were labeled with ReAsH (red
bar) and imaged (open circle). (B) Localization of newly synthesized core protein over time. Old core labeled with FlAsH (left column) and new core
labeled with ReAsH (middle column) are shown together with ADRP in merged images (right column) at each timepoint. For the 8 h timepoint, cells
were incubated630 mM cycloheximide (CHX) to halt protein synthesis. Newly synthesized core was not detected in CHX-treated cells. For all images,
scale bar is 10 mm and nuclei (N) are shown for reference. (C) Quantification of old and new core localization over time. The mean number of LD-
associated core (top panel) and core puncta (bottom panel) per cell at each timepoint were calculated as described in Materials and Methods. For
both graphs, values show mean number of particles at each time point 6 SEM (n= 74 to 98). Statistical analysis was used to compare the change in
each particle type over time. Asterisks indicate that a statistically significant change was observed in comparison to the previous time point (Student’s
t-test, p,0.05).
doi:10.1371/journal.ppat.1002302.g004
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live cell imaging bypasses the need for fixation, which can alter the
localization of LD-associated proteins [47]. In the current study,
TC-tagging and labeling with biarsenical dyes had minimal effects
on viral replication, core protein expression, or virus particle
production. Furthermore, the optimized labeling conditions used
here [48] were specific for TC-tagged core protein. Thus, these
methods can be used to confidently track functional core protein.
Despite repeated attempts, we did not observe FlAsH-labeled
extracellular virus particles. This could be explained by several
considerations. First, FlAsH label may be inefficiently incorporat-
ed into virus particles, perhaps displaced from the TC tag during
RNA packaging. Alternatively, incorporated FlAsH label could be
quenched or too dim to image reliably. The detection of
extracellular virus particles may also be hampered by the low
burst size of HCV [34], the inherent pulse-type labeling with
biarsenical dyes, and the propensity of these reagents to photo-
bleach. Nevertheless, we were able to reliably image intracellular
forms of HCV core protein.
Three forms of core protein were observed in live cells: ER-
associated core, LD-associated core, and motile, LD-independent
puncta. On LDs, core formed polarized caps that displaced ADRP
and were frequently in close apposition to ER-localized core.
Similar LD-associated caps of core protein were previously seen in
fixed cells by IF staining [24,49], and likely reflect sites of core
protein transfer between the ER and LDs. Consistent with this
model, newly synthesized core was directed to LDs that already
contained older core. These data suggest that core-containing LDs
maintain direct communication with the ER for extended periods
of time or that LDs containing old or new core can fuse to allow
mixing.
Figure 5. The interactions between NS2 and NS3 are essential for recruiting core from LDs. (A) Localization of core in cells expressing
ADRP-CFP electroporated with the indicated viral transcript. Panels show ADRP, core, and merged images; scale bars are 10 mm. (B) The NS2 K27A
mutant shows enhanced accumulation of core around LDs. Quantification was performed as described in Materials and Methods; values show mean
percent LD surface area occupied by core 6 SEM (n$10). (C) Enhanced accumulation of intracellular core in the presence of NS2 mutations (left
panel) 6 NS3 Q221L suppressor (right panel). Quantification was performed as described in Materials and Methods (n.38). Horizontal bars represent
mean values, asterisks indicate statistically significant differences from WT (Student’s t-test, p,0.05). (D–E) Dual labeling of LD-associated core and
core puncta in the presence of NS2 Y39A mutation6 NS3 Q221L. Cells were electroporated with the indicated viral transcript then labeled with FlAsH
followed by ReAsH after an 8 h chase. The mean number of LD-associated core (left panel) and core puncta (right panel) per cell at each timepoint
were calculated as described in Materials and Methods. For all graphs, values show mean number of particles at each time point6 SEM (n= 23 to 71).
For comparison with WT, please refer to Figure 4C.
doi:10.1371/journal.ppat.1002302.g005
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Large core-containing LDs were immotile during the time
periods we observed, which coincided with the peak of virus
particle assembly. Prior studies have shown that infection with
HCV strain JFH-1 or overexpression of core protein causes
microtubule-based trafficking of LDs to the perinuclear region
[49,50]. In our hands, attempts to image core at significantly
earlier times were unfruitful due to low levels of core expression
and dim staining. Nevertheless, we did observe core-containing
LDs clustered in the perinuclear region, suggesting that they had
either formed there or moved there prior to staining.
Although LD-associated core has been implicated in virus
particle assembly, it has been difficult to demonstrate a direct role
for core-LD trafficking in this process. Boulant and colleagues
proposed that progressive trafficking of core onto LDs strongly
correlates with a rise in infectious virus production [24].
Furthermore, the accumulation of core on LDs inversely correlates
with the efficiency of virus production, exemplified by the different
localization patterns observed for viruses with high (Jc1) and low
(JFH1) infectious titers [22,26]. Similarly, we observed dramatic
increases in the amount of LD-associated core with an HCV
deletion mutant that is unable to assemble virus particles.
In addition to LD-associated core, we also observed motile core
puncta that were not LD-associated. We propose that motile core
puncta represent a form of core relevant for virus assembly based
on the following considerations: 1) the formation of motile core
puncta was blocked in the D88 mutant, which is unable to
assemble virus particles (Figure 2F and Video S4); 2) the formation
of motile puncta after BFA washout indicated that they represent a
post-LD form of core (Figure 3); and 3) newly synthesized core
trafficked to LDs before it trafficked to motile puncta (Figure 4).
These data suggest that puncta represent transport vesicles
containing virus particles or an intermediate in virus particle
assembly. For instance, Lai and colleagues recently showed that
core may traffic to a compartment containing early endosomal
markers during virus particle secretion [51].
It was interesting that core accumulated on the surface of LDs
during BFA treatment (Figure 3B–D), suggesting that ARF1 activity
is required for the egress of core from LDs. This would be consistent
with a defect in virus assembly, as was seen for the D88 mutant
(Figure 2F) and the class 1 NS2 mutants (Figure 5). While BFA
inhibited virus secretion, intracellular virus particles still assembled
during treatment (Figure 3F–G and S4A–B). One possibility is that
virus particles made during BFA treatment may utilize the available
ER-associated pool of core; presumably then BFA would cause a
defect in virus assembly once this pool is depleted. In addition, BFA
may slow the egress of core from LDs and reduce the rate of virus
assembly. A full accounting of infectious virus production could be
used to discriminate between these possibilities.
Taken together, our data support the model for core trafficking
depicted in Figure 6A. Core protein is synthesized on the ER and
trafficked to LDs, which remain in direct or indirect communi-
cation with the ER. During virus assembly, core protein is
recruited from the surface of LDs and into puncta, which likely
represent transport vesicles containing virus particles or possibly a
core-containing intermediate.
To further explore our model of core trafficking, we utilized our
live-cell imaging tools to study the role of NS2 in virus assembly.
The class 1 NS2 mutants all showed a large accumulation of core
around LDs and fewer core puncta, and core trafficking was
restored by the NS3 Q221L second-site suppressor mutation in the
viral RNA helicase. In contrast the NS2 K81A mutant showed
normal core-LD trafficking. This mutant was previously found to
have a distinct defect in virus particle assembly, exhibits normal
levels of interaction between NS2 and NS3-4A [45], and is not
rescued by the NS3 Q221L mutation [46]. By using sequential
labeling, we showed that a block in virus assembly caused an
accumulation of old core on LDs and a vast reduction in newly
synthesized core on LDs. Thus, the assembly defect results in
either reduced synthesis of core, or increased turnover. Impor-
tantly, there was a distinct lack of puncta containing newly
synthesized core. Taken together, these data strongly suggest that
NS2, and more specifically, the interaction between NS2 and
NS3-4A, is important to recruit core off the surface of LDs and
into core-containing puncta.
Although NS2 is important for the recruitment of core from
LDs, NS2 does not directly interact with core protein [43,44,45].
How then does NS2 contribute to core trafficking? NS2
coordinates virus particle assembly by bringing together the viral
structural and NS proteins (Figure 6B). We propose that the
interaction with NS2 may signal to NS3-4A that it is time to stop
replicating viral genomes and to start packaging them. Thus, the
NS2-NS3 interaction would supply RNAs for packaging; in the
absence of proper interaction between NS2 and NS3-4A, core
may accumulate on LDs due to a lack of viral RNA for packaging.
Figure 6. Models of core trafficking and virus assembly. (A) Our model of core protein trafficking is illustrated here. The question mark
indicates that the process of virus assembly is still poorly understood. (B) Our model of virus particle assembly. Virus particle assembly likely requires
the simultaneous recruitment of core protein from the surface of LDs and viral RNA from replication complexes, while nascent virus particles bud into
the ER lumen. NS2 helps to coordinate this process by bringing together viral structural and NS proteins.
doi:10.1371/journal.ppat.1002302.g006
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In summary, we have developed methods to image functional
core protein in live cells. This system allows us to study trafficking
of core protein in virus-producing cells, and revealed several novel
aspects of core trafficking, including a role for interaction between
NS2 and NS3-NS4A in the egress of core from the surface of LDs.
Materials and Methods
Plasmids
Plasmids pJc1 and pJc1/Gluc2A were recently described [46].
Jc1/core(TC) was constructed in multiple steps. First, the Jc1 59
noncoding region (NCR)-core junction was amplified by using
KlenTaq-LA (DNA Polymerase Technology, St. Louis, MO) with
oligos YO-0021 (59-AGA CCG TGC ACC ATG AGC TTT
CTC AAT TGT TGT CCT GGC TGT TGT ATG GAA CCT
AGC GGA TCC ACA AAT CCT AAA CC-39) and YO-0028
(59-CCA CGT GCA GCC GAA CCA-39). The amplicon was
cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA) and
sequenced. The modified 59 NCR-core junction was then
subcloned as a 767-bp ApaLI/AgeI fragment into pJc1 [46] by
using common restriction sites.
pJc1/core(TC) D88 was constructed by ligating a 9193-bp ClaI
fragment of pJc1/core(TC) and a 1381-bp ClaI fragment from
pJc1/NS2(AP) D88 [45]. Plasmids containing NS2 mutations in a
Jc1/Gluc2A background were recently described [46]. To
facilitate cloning, the Gluc2A gene was inserted into pJc1/
core(TC) by using common BsaBI and NotI sites. The EcoRI/
MluI fragment from this plasmid was then subcloned into the same
sites of Jc1/Gluc2A plasmids containing NS2 mutations, which
served to simultaneously introduce the TC tag and excise the
Gluc2A gene. Plasmids containing suppressor mutations were
created in a similar manner.
To construct lentiviral vectors containing fluorescent protein-
tagged cellular markers, pLenti4/EGFP (Invitrogen) was modified
to introduce a SpeI site into the multi cloning site. This was done
by annealing oligos YO-0183 (59-GAT CCA CTA GTC TGC
AGT CCG GAC-39) and YO-0184 (59-CAC TAG TCT GCA
GTC CGG ACT CGA-39) and ligating them into pLenti4/EGFP
cut with BamHI and XhoI to create pLenti/MCS. The NheI/
Bsp120I fragment from pLA4 (a kind gift of J. McLauchlan [52])
was subsequently cloned into the SpeI/Bsp120I sites of pLenti/
MCS to generate pLenti/GFP-ADRP. To create a CFP-tagged
version, the NheI/BsrGI fragment of pCerulean-C1 was sub-
cloned into the XbaI/BsrGI sites of pLenti/GFP-ADRP. Fluo-
rescent protein-tagged ADRP was shown to co-localize with
anti-ADRP antibody by IF (data not shown). To construct a
fluorescent protein-tagged tubulin vector, the tubulin gene was
excised from pmTFP-tubulin (Allele Biotechnology, San Diego
CA) by using BglII and BamHI and subcloned into the BglII site of
pTagRFP-C (Evrogen, Moscow Russia) previously modified to
contain a S158T mutation that enhances photostability [53]. The
mTagRFP(T)-tubulin gene fusion was then excised with NheI and
SacII and subcloned into the SpeI/SacII sites of pLenti/MCS to
create pLenti/RFP-tubulin. To express red fluorescent protein-
tagged Rab18, mTagRFP(T) was subcloned into pEGFP-Rab18 (a
gift from I. Derre) by using common AgeI and BglII sites. A
BamHI fragment containing the mTagRFP(T)-Rab18 fusion was
then subcloned into pLenti/MCS to create pLenti/RFP-Rab18.
For ER-labeling, pmTagRFP(T) was modified to introduce a
signal peptide by annealing oligos YO-0412 (59-CTA GCC GCC
ACC ATG GCC CTG CTG AGC GTG CTG CTG CTG CTG
GGC CTG CTG GGC CTG GCC GTG GCC AAG-39) and
YO-0413 (59-GAT CCT TGG CCA CGG CCA GGC CCA
GCA GGC CCA GCA GCA GCA GCA CGC TCA GCA GGG
CCA TGG TGG CGG-39). The plasmid was further modified to
incorporate an ER retention signal (KDEL) by annealing oligos
YO-0426 (59-GAT CCC GCG CGC CAA GCT TG-39) and YO-
0415 (59-AAT TCT CGA GTT ACA GCT CGT CCT TCT T-39)
to create pmTag/RFP-KDEL. The signal peptide-RFP-KDEL
fusion was then excised by using NheI and XhoI sites and ligated
into the SpeI-XhoI sites of pLenti/MCS to create pLenti/RFP-
KDEL. pGalT-CFP was a kind gift of N. Altan-Bonnet.
Cell culture and reagents
Huh-7.5 (a kind gift of C.M. Rice [54]) and 293T cells were
maintained in Dulbecco’s modified Eagle medium (Invitrogen)
containing 10% fetal calf serum (Hyclone, Waltham MA) and 1
mM nonessential amino acids (Invitrogen). Huh-7.5 cell lines
expressing fluorescent-tagged proteins were derived by lentiviral
transduction. Briefly, lentiviral vectors were packaged in 293T
cells by using the ViraPower packaging system (Invitrogen) and
used to transduce Huh-7.5 cells. Stable cell lines were selected and
maintained by using standard growth medium containing 100 mg/
ml Zeocin (InvivoGen, San Diego CA).
Antibodies used for immunoblotting and IF included anti-b
actin (Sigma, St. Louis MO), anti-core C7-50 (Affinity BioR-
eagents, Waltham MA), anti-E2 C1 (a kind gift of D. Burton [55]),
anti-GFP (Invitrogen) and anti-NS3 (Virogen, Watertown MA).
Bodipy 493/503 (Invitrogen) was used to label neutral lipids as per
manufacturer’s instructions. Transient transfections were per-
formed by using TransIT LT1 (Mirus, Madison WI) or Fugene 6
(Roche, Indianapolis IN) transfection reagents according to
manufacturer’s instructions.
Nocodazole (Sigma) was dissolved at 25 mM in dimethylsulf-
oxide and diluted to 50 mM final concentration. (Z-LL)2-ketone
(EMD BioSciences, Gibbstown NJ) was dissolved at 100 mM in
dimethylsulfoxide and diluted to 100 mM final concentration.
Cycloheximide (MP Biomedical, Costa Mesa, CA) was dissolved at
100 mM in ethanol and diluted to 30 mM final concentration.
Brefeldin A (BFA; Sigma) was dissolved at 5 mg/ml in ethanol and
diluted to 1 or 5 mg/ml final concentration. The amount of BFA
used and the time of BFA treatment were optimized in pilot
experiments by measuring Gaussia luciferase secretion (Figure
S3A), virus secretion (Figure S3B), and GalT-GFP redistribution
(data not shown). Oleic acid (Sigma; 400 ng/well) was added to
cells 30 min prior to imaging.
HCV electroporation and infection
Cells were transfected with HCV RNA transcripts by
electroporation, as previously described [56] and seeded onto
coverslips in 24-well plates, or into glass-bottom plates (MatTek,
Ashland MA). For infection experiments, cells were seeded onto
coverslips or glass-bottom plates, and inoculated with virus at 12–
24 h post seeding. Luciferase assays were performed on viral
supernatants as previously described [46]. Absolute values of viral
infectivity were determined by using an endpoint dilution assay as
previously described [57]. Briefly, virus was serially diluted into
complete growth medium and each dilution was used to infect
multiple wells of a 96-well plate. Fifty percent endpoint dilutions
were calculated after wells were immunostained with anti-NS5A
9E10 antibody. To measure intracellular infectivity, cells were
harvested by trypsinization at 48 h post-transfection, centrifuged at
1200 rpm for 5 min, resuspended in complete medium and subject
to three rounds of freezing (2196u in liquid nitrogen) and thawing
(37uC). Cellular debris was removed by centrifugation at 10,000
rpm for 5 min and supernatants tested for infectivity as described
above.
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Isopycnic ultracentrifugation
Preformed iodixanol gradients were prepared on a Gradient
Master 107 (BioComp, Fredericton, Canada) by using 10 and 40%
(w/v) Optiprep (Axis-Shield,Oslo, Norway) in PBS. For equilibrium
sedimentation, 1ml of each virus was layered on top of the gradient
and centrifuged at 40,000 rpm for 14 h at 4uC in an SW-41rotor.
Fractions (1ml) were collected from the bottom of the gradient after
tube puncture with a fraction collection system (Brandel, Gaithers-
burg MD). Buoyant densities were determined by refractometry on
a handheld refractometer (Reichert, Depew NY).
RNA quantitation
RNA was extracted from fractions or cell culture medium and
quantitated using real-time reverse transcription (RT) PCR as
previously described [46]. Briefly, reactions were run with the
LightCycler RNA amplification.
HybProbe kit (Roche Applied Sciences, Mannheim, Germany)
containing 2 ml RNA sample or RNA quantitation standards, 8
mM MgCl2, 375 nM each primer, 250 nM probe, and 1 U RNase
inhibitor (United States Biochemical,Cleveland, OH). Reactions
were run on a Roche LightCycler 480. Specific infectivity was
calculated as the infectivity per RNA copy.
Tetracysteine labeling with biarsenical dyes
Cells were labeled with FlAsH or ReAsH reagents (Invitrogen)
between 48 and 72 h post-infection or post-electroporation with
Jc1/core(TC). Immediately prior to diluting, either reagent was
mixed with 10 mM 1,2-ethanedithiol (EDT; Sigma). The biarse-
nical dye-EDT mixture was further diluted in Hanks Balanced Salt
Solution (HBBS; Invitrogen) containing 1 mM sodium pyruvate
(Invitrogen), 10 mM glucose (Sigma), 1 mM Patent Blue V (Sigma)
and 20 mM Disperse Blue 3 (Sigma). Prior to use, Disperse Blue 3
was purified by recrystallization from toluene. After 2 brief washes
in HBBS, cells were incubated with FlAsH or ReAsH-containing
labeling mixture for 20 min at 37uC, then washed 3 times at 37uC
for 10 min with HBSS containing 1 mM 2,3-dimercapto-1-
propanol (British anti-Lewisite [BAL]; Sigma), and further washed
with HBSS prior to imaging.
For dual labeling experiments, cells were labeled with 2 mM
FlAsH, as described above, for 40 min. Immediately after
incubation, cells were briefly rinsed once with HBSS and complete
growth medium added to each dish. Cells were incubated for 2 to
24 hours, before being labeled with 0.32 mM of ReAsH, as
described above, and washed with HBSS containing BAL.
Immunofluorescence
Cells seeded on coverslips were fixed with 4% paraformalde-
hyde (PFA) for 20 min at room temperature (RT), then washed
twice in PBS containing 100 mM glycine. Cells were permeabi-
lized and blocked in PBS containing 1% BSA (Sigma) with 0.1%
saponin (Sigma). Primary antibodies (diluted in the same solution)
were added for 1 to 3 h at RT before being washed off with PBS.
Secondary Alexa-Fluor antibodies (488 or 568; Invitrogen) were
used to label the primary signal. After 1 h incubation and washing,
the coverslips were mounted on slides by using Prolong Antifade
Gold reagent (Invitrogen).
Microscopy
Live cell confocal imaging was performed by using a 606
objective on a Nikon TE2000 PFS-2 microscope (Nikon, Tokyo
Japan) equipped with a Perfect Focus system (Nikon), Volocity
spinning disc confocal unit (Improvision, Waltham MA), and live
cell chamber (37uC, 5% CO2; Pathology Devices, Westminster
MD). Fixed cell fluorescence was performed by using the same
instrument without the live cell chamber or Perfect Focus system.
Images were edited by using Volocity (Improvision), ImageJ
(NIH), or Photoshop (Adobe, San Jose CA) software. Single
particle tracking was performed by using the Volocity Quantita-
tion software package (Improvision).
Quantitation of images was performed using the Measurement
function in the Volocity software package. To quantify the total
number of core particles, the number of objects with volume
.0.5 mm3 and pixel intensity in the FlAsH or ReAsH channel
above background were counted. Background was calculated for
each channel as three times the mean pixel intensity of mock-
infected cells. Similar methods were used to calculate total LD
numbers. LD-associated core was measured by selecting objects
with volume .0.5 mm3, and pixel intensities greater than
background in both the core and ADRP channels. Total core
volume was estimated by summing the volume of core particles
within the cell. Total cell volume was estimated by tracing the cell
outline and using Volocity volume calculations. Relative core per
cell was calculated by dividing total core volume by total cell
volume. To calculate the surface area of LDs occupied by core, the
surface area of core was determined as the sum of the voxels and
expressed as a percentage of the total surface area of the LD. Co-
localization was performed in ImageJ by using the Co-localization
Finder and PSC Co-localization plugins as previously described
[58]. Quantitations performed in Figures 3 through 5 were done in
a blinded manner.
Immunoblotting
Huh-7.5 cells (seeded in 6-well plates) were washed twice with
Dulbecco’s PBS, lysed in 400 ml sample buffer (50 mM Tris [pH
6.8], 100 mM dithiothreitol, 2% [wt/vol] SDS, 10% [vol/vol]
glycerol, 0.1% [wt/vol] bromophenol blue), and homogenized by
multiple passes through 22- and 28-gauge needles. Electrophoresis
and western blotting were performed as previously described [46].
Statistical methods
Statistical analyses (unpaired Student’s t-test) were performed by
using Prism 4 software (GraphPad, La Jolla, CA).
Supporting Information
Figure S1 Characterization of tagged and untagged Jc1.
(A) The infectivity profiles of Jc1 (top) and Jc1/core(TC) (bottom)
are shown after isopycnic centrifugation in a 10 to 40% iodixanol
gradient. Infectivity values are plotted against buoyant density. (B)
The specific infectivity of each fraction in panel (A) was calculated
as the infectivity per RNA copy (TCID50/ml divided by RNA
copies/ml) and plotted against the buoyant density.
(EPS)
Figure S2 Effect of fixation and IF processing on FlAsH
staining. Huh-7.5 cells were seeded onto two adjacent cover slips
placed in a single 30-mm plate, and infected with Jc1/core(TC).
Forty eight hours later, the cells were stained with FlAsH, and one
cover slip was imaged under live imaging conditions; the parallel
coverslip was fixed in 4% paraformaldehyde, processed for core IF
as in Figure 1G, and imaged under identical settings (120 ms
exposure; 3 camera gain; 220 camera sensitivity; 2.59 green laser
intensity). (A) Representative images from live cells and cells that
were fixed and processed for IF. Scale bars, 10 mm. (B) The
number of bright FlAsH-labeled objects (average pixel intensity
.5000) were counted from 21 random fields by using Volocity
software. This threshold was chosen because it discriminates true
FlAsH labeling from background fluorescence. Results are shown
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as the mean 6 SEM; the p-value was calculated by using the
unpaired Student’s t-test.
(EPS)
Figure S3 Characterization of LDs. (A) Schematic of the
Jc1/Gluc2A reporter genome [44]. Polyprotein cleavage sites are
indicated as in Figure 1A. The star indicates C-terminal
autocleavage by the foot-and-mouth disease virus 2A peptide,
which was fused downstream of the Gaussia princeps luciferase gene
[44]. Copyright  American Society for Microbiology, Journal
of Virology, volume 83, 2009, pp. 8379–8395 doi:10.1128/
JVI.00891-09. (B) Huh-7.5 cells expressing tagged ADRP support
HCV particle assembly. The indicated cells were electroporated
with the Jc1/Gluc2A reporter genome. The infectivity of secreted
virus produced by Huh-7.5 (black line), Huh-7.5/GFP-ADRP
(green line), or Huh-7.5/CFP-ADRP (blue line) cells are shown for
each time point. Data show mean RLU from triplicate
experiments 6 SEM. The grey line shows the background level
of the assay. The mean HCV titers produced at each time point by
Huh-7.5/CFP-ADRP and Huh-7.5/GFP-ADRP cells did not
significantly differ from the mean HCV titers produced by Huh-
7.5 cells (NS; p .0.05; unpaired Student’s t-test). (C) ADRP
protein expression. The level of endogenous ADRP in Huh-7.5
cells was compared with cells expressing GFP- or CFP-tagged
ADRP. Tagged ADRP (open arrowhead) was not overexpressed
relative to endogenous ADRP (closed arrowhead). Actin loading
controls are shown for comparison between samples. (D) LD
volume in Huh-7.5 cells and CFP-ADRP-expressing cells. The
average LD volumes were determined in each cell type, with and
without oleic acid (OA) treatment (6 SEM; n = 65-89), after
staining with Bodipy 493/503. Quantitation was performed as
described in Materials and Methods. No statistically significant
difference in mean LD volume was observed (p .0.05; unpaired
Student’s t-test). (E) Co-localization of core with ER. Infected cells
expressing an ER-retained RFP were labeled with FlAsH and
imaged. When the intensity of FlAsH-labeled core was enhanced,
co-localization between both signals was observed. (F) Core
localized to the periphery of LDs and to LD-independent puncta.
Huh-7.5 cells were labeled with ReAsH and Bodipy 493/503 at 48
h post-infection. (G) Localization of LD markers in Huh-7.5 cells.
Cells were transiently transfected with fluorescent protein-tagged
Rab18 and ADRP constructs and imaged 48 h post-transfection.
(H) Core preferentially localizes to ADRP-positive LDs. Cells
transiently transfected with ADRP (left panel) or Rab18 (middle
panel) were labeled with ReAsH (red) at 48 h post-infection. Co-
localization (right panel) was calculated by using Volocity
Quantitation software (n = 20). (I) The D88 mutant had enhanced
accumulation of core around LDs. Quantification was performed
as described in Materials and Methods; values show mean percent
LD surface area occupied by core 6 SEM (n$10). All scale bars,
10 mm.
(EPS)
Figure S4 Effect of BFA on protein and virus secretion.
(A) Extracellular and intracellular luciferase excretion. At 48 h
post-transfection, parallel cultures were treated with BFA (5 mg/
ml) for 8 h (blue line) or left untreated (black line). Supernatants
and cells lysates were harvested at the indicated times and used to
determine the levels of extracellular and intracellular luciferase
activity, as indicated. (B) Samples from panel A were used to infect
naı¨ve Huh-7.5 cells, followed by extensive washing with PBS. The
relative levels of extracellular and intracellular infectivity were
quantitated by measuring secreted luciferase production at 72 h
post-infection. For all graphs, values show mean RLU from
triplicate experiments 6 SEM. The solid gray bars on each graph
indicate the interval of BFA treatment and the black dashed lines
indicate the background RLU in these assays. Asterisks indicate
significant differences between mock and BFA treated cells
(p,0.05; unpaired Student’s t-test). (C) Effect of BFA on LDs.
Right panel: ADRP protein levels in Huh-7.5 cells expressing
CFP-ADRP treated with BFA (1 mg/ml for 4 h) or carrier
(ethanol). Levels of tagged ADRP (open arrowhead) and
endogenous ADRP (closed arrowhead) were comparable. The
LD number (left graph) and LD volume (right graph) 6 BFA
treatment (1 mg/ml for 4 h) were determined after labeling with
Bodipy 493/503. Mean LD number or LD volume per cell (n.23)
6 SEM are shown. Asterisk indicates a significant difference
between mock and BFA treated cells (p,0.05; unpaired Student’s
t-test).
(EPS)
Figure S5 Specificity of dual labeling for old and new
core protein. Parallel cultures of Huh-7.5 cells expressing CFP-
ADRP were FlAsH-labeled at 48 h post-infection (green bar),
labeled 8 h later with ReAsH (red bar), then imaged (open circle).
Old core labeled with FlAsH (left column) and new core labeled
with ReAsH (middle column) are shown together with ADRP in
merged images (right column). (A) New core is detected on LDs
already containing old core 8 h after translation. Note that this is
the same image from Figure 4B for comparison. (B) Maturation of
newly synthesized core is required for LD localization. Cells were
treated with 100 mM signal peptide peptidase inhibitor (SPPi) to
inhibit the maturation of newly synthesized core during the chase
phase, then labeled with ReAsH and imaged. Newly synthesized
core was not targeted to LDs, but to large aggregates. (C) Cells
were treated as described in B, but cells were imaged 4 h after
SPPi washout. Newly made core was targeted to LDs. For all
images, scale bar is 10 mm.
(EPS)
Figure S6 Intracellular accumulation of core. (A) Cells
expressing GFP-ADRP were electroporated with the indicated
viral transcript and labeled with ReAsH 48 h post-electroporation.
Enhanced accumulation of core was observed for all class 1 NS2
mutants (K27A, W35A, Y38A) but not the class 2 mutant (K81A).
Scale bar is 10 mm. (B). Quantitation of intracellular core in fixed
cells. To validate data obtained in Figure 5C, similar quantitation
was done on non-transduced Huh-7.5 cells transfected with
untagged wild-type (WT) Jc1, Jc1/NS2 K27A, or Jc1/NS2 K27A
+ NS3 Q221L. Core was visualized by IF with anti-core antibody.
Quantitation was done as described in Materials and Methods
(n = 34–43 cells per transfection). Horizontal bars represent mean
values, asterisks indicate significant differences from WT (p,0.05;
unpaired Student’s t-test).
(EPS)
Video S1 Intracellular localization of core protein. GFP-
ADRP expressing cells (green) were labeled with ReAsH (red) at
48 h post-infection. Three forms of core were observed: i) ER-
associated core; ii) core associated with ADRP-positive LDs; (iii)
ADRP-independent core. ADRP-independent core puncta show
motility. Images were captured every 90 sec, scale bar is 17 mm.
(AVI)
Video S2 Trafficking of core protein on microtubules.
Cells expressing tubulin-RFP cells (red) were labeled with FlAsH
(green). Core puncta were seen trafficking on microtubules.
Frames were captured every 1 min, scale bar is 17 mm.
(MOV)
Video S3 Limited trafficking of core protein on micro-
tubules in the presence of 50 mM Nocodazole. Cells
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expressing tubulin-RFP (red) were treated with 50 mM Nocodazole
and labeled with FlAsH (green) 48 h post infection, as described
for Video S2. Puncta have reduced motility compared with non-
treated cells (Video S2). Frames were captured every 20 sec, scale
bar is 17 mm.
(MOV)
Video S4 Limited motility of core protein in D88
mutant. Cells expressing tagged-ADRP (red) were electroporated
with Jc1/core(D88) and labeled with FlAsH (green). Core puncta
are reduced in number and are non-motile. Frames were captured
every 15 sec, scale bar is 4.4 mm.
(MOV)
Video S5 Core motility during BFA treatment. Huh-7.5
cells were FlAsH-labeled at 48 h post-infection with Jc1/core(TC),
treated with 1 mg/ml BFA for 3 h, and imaged for 29 min. Frames
were captured every 47 sec, scale bar is 8 mm.
(MOV)
Video S6 Core motility after BFA washout. Cells were
treated with BFA as in Video S5, washed twice with Hank’s
buffered saline, and imaged for 40 min. Frames were captured
every 91 sec, scale bar is 8 mm.
(MOV)
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